Data source
malaria, malaria infection
MALARIA, MALARIA
The trial was a four arms, single-blinded, cluster randomized factorial design conducted in Muleba district in the northwestern part of Tanzania from 2015 to 2017. This trial is registered with ClinicalTrials.gov, number NCT02288637. The detail of the parent study procedures have been described elsewhere [Standard LLNs (Olyset ® Net, Sumitomo Chemicals, Japan)PBO LLIN (Olyset ® Plus, Sumitomo Chemicals, Japan)Standard LLIN with IRS (Actellic® 300CS, Syngenta, Switzerland)PBO LLIN with IRS (Actellic® 300CS, Syngenta, Switzerland)To assess the effectiveness of each intervention, household cross-sectional surveys were conducted in June and December of each year. A questionnaire was administered to obtain information on household and individual social demographic and economic factors including the availability and use of malaria prevention measures. Children aged 6 months to 14 years were tested for malaria infection using a rapid diagnostic test (CareStart Malaria HRP2/pLDH (pf/PAN) Combo, DiaSys, UK).